BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31726379)

  • 1. Next generation sequencing for GNAS uncovers CD34 as a sensitive marker for intramuscular myxoma.
    Libbrecht L; Bempt IV; Schubert T; Sciot R; Galant C
    Ann Diagn Pathol; 2019 Dec; 43():151409. PubMed ID: 31726379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of GNAS mutations in intramuscular / cellular myxomas as diagnostic tool in the classification of myxoid soft tissue tumors.
    Sunitsch S; Gilg MM; Kashofer K; Gollowitsch F; Leithner A; Liegl-Atzwanger B
    Diagn Pathol; 2018 Aug; 13(1):52. PubMed ID: 30111377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel GNAS mutations in intramuscular myxoma using next-generation sequencing with single-molecule tagged molecular inversion probes.
    Bekers EM; Eijkelenboom A; Rombout P; van Zwam P; Mol S; Ruijter E; Scheijen B; Flucke U
    Diagn Pathol; 2019 Feb; 14(1):15. PubMed ID: 30736805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intramuscular myxoma of the lower leg].
    Luebke AM; Gocke C; Priemel M; Grob TJ; Zustin J
    Pathologe; 2013 Jul; 34(4):360-3. PubMed ID: 23179208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Karyotyping and analysis of GNAS locus in intramuscular myxomas.
    Panagopoulos I; Gorunova L; Lobmaier I; Bjerkehagen B; Heim S
    Oncotarget; 2017 Mar; 8(13):22086-22094. PubMed ID: 28160572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Methylation Analysis in Distinguishing Cellular Myxoma from Low-Grade Myxofibrosarcoma.
    Henzinger H; Brčić I; Igrec J; Godschachner TM; Scheipl S; Szkandera J; Jurmeister P; Liegl-Atzwanger B
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
    Singhi AD; McGrath K; Brand RE; Khalid A; Zeh HJ; Chennat JS; Fasanella KE; Papachristou GI; Slivka A; Bartlett DL; Dasyam AK; Hogg M; Lee KK; Marsh JW; Monaco SE; Ohori NP; Pingpank JF; Tsung A; Zureikat AH; Wald AI; Nikiforova MN
    Gut; 2018 Dec; 67(12):2131-2141. PubMed ID: 28970292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscular myxoma of the cervical muscles with GNAS mutation.
    Pilloni G; Ajello M; Melcarne A; Marengo N; Zenga F; Garbossa D; Ducati A; Tartara F
    J Neurosurg Sci; 2019 Aug; 63(4):485-487. PubMed ID: 29115102
    [No Abstract]   [Full Text] [Related]  

  • 9. Juxta-articular myxoma and intramuscular myxoma are two distinct entities. Activating Gs alpha mutation at Arg 201 codon does not occur in juxta-articular myxoma.
    Okamoto S; Hisaoka M; Meis-Kindblom JM; Kindblom LG; Hashimoto H
    Virchows Arch; 2002 Jan; 440(1):12-5. PubMed ID: 11942570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma.
    Delaney D; Diss TC; Presneau N; Hing S; Berisha F; Idowu BD; O'Donnell P; Skinner JA; Tirabosco R; Flanagan AM
    Mod Pathol; 2009 May; 22(5):718-24. PubMed ID: 19287459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitive Sequencing Analysis Suggests Thyrotropin Receptor and Guanine Nucleotide-Binding Protein G Subunit Alpha as Sole Driver Mutations in Hot Thyroid Nodules.
    Stephenson A; Eszlinger M; Stewardson P; McIntyre JB; Boesenberg E; Bircan R; Sancak S; Gozu HI; Ghaznavi S; Krohn K; Paschke R
    Thyroid; 2020 Oct; 30(10):1482-1489. PubMed ID: 32284013
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence and Clinical Features of Mazabraud Syndrome: A Multicenter European Study.
    Majoor BCJ; van de Sande MAJ; Appelman-Dijkstra NM; Leithner A; Jutte PC; Vélez R; Perlaky T; Staals EL; Bovée JVMG; Hamdy NAT; Dijkstra SPD
    J Bone Joint Surg Am; 2019 Jan; 101(2):160-168. PubMed ID: 30653046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cases of Mazabraud syndrome and identification of a GNAS R201H mutation by next-generation sequencing.
    Cox JL; Cushman-Vokoun AM; McGarry SV; Kozel JA
    Virchows Arch; 2017 May; 470(5):589-593. PubMed ID: 28258512
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of GNAS1 mutations in myxoid soft tissue and bone tumors.
    Walther I; Walther BM; Chen Y; Petersen I
    Pathol Res Pract; 2014 Jan; 210(1):1-4. PubMed ID: 24268734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers.
    Parish AJ; Nguyen V; Goodman AM; Murugesan K; Frampton GM; Kurzrock R
    Cancer; 2018 Oct; 124(20):4080-4089. PubMed ID: 30204251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study.
    Pietrantonio F; Berenato R; Maggi C; Caporale M; Milione M; Perrone F; Tamborini E; Baratti D; Kusamura S; Mariani L; Niger M; Mennitto A; Gloghini A; Bossi I; Settanni G; Busico A; Bagnoli PF; Di Bartolomeo M; Deraco M; de Braud F
    J Transl Med; 2016 May; 14(1):125. PubMed ID: 27154293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next generation sequencing of the cellular and liquid fraction of pancreatic cyst fluid supports discrimination of IPMN from pseudocysts and reveals cases with multiple mutated driver clones: First findings from the prospective ZYSTEUS biomarker study.
    Volckmar AL; Endris V; Gaida MM; Leichsenring J; Stögbauer F; Allgäuer M; von Winterfeld M; Penzel R; Kirchner M; Brandt R; Neumann O; Sültmann H; Schirmacher P; Rudi J; Schmitz D; Stenzinger A
    Genes Chromosomes Cancer; 2019 Jan; 58(1):3-11. PubMed ID: 30230086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation sequencing of endoscopic ultrasound guided microbiopsies from pancreatic cystic neoplasms.
    Vestrup Rift C; Melchior LC; Kovacevic B; Toxvaerd A; Klausen P; Karstensen JG; Kalaitzakis E; Storkholm J; Palnaes Hansen C; Vilmann P; Preuss Hasselby J
    Histopathology; 2019 Nov; 75(5):767-771. PubMed ID: 31278869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative and sensitive detection of GNAS mutations causing mccune-albright syndrome with next generation sequencing.
    Narumi S; Matsuo K; Ishii T; Tanahashi Y; Hasegawa T
    PLoS One; 2013; 8(3):e60525. PubMed ID: 23536913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRAS and GNAS Co-Mutation in Metastatic Low-Grade Appendiceal Mucinous Neoplasm (LAMN) to the Ovaries: A Practical Role for Next-Generation Sequencing.
    Matson DR; Xu J; Huffman L; Barroilhet L; Accola M; Rehrauer WM; Weisman P
    Am J Case Rep; 2017 May; 18():558-562. PubMed ID: 28526814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.